Placental Stem Cell Therapy Market: Introduction
According to the report, the global placental stem cell therapy market was valued at US$ 0.5 Bn in 2019. It is projected to expand at a CAGR of 20% from 2020 to 2030. The placenta is an organ that connects the developing fetus to the uterine wall, enabling a flow of nutrients, gases, and hormones between the mother and the fetus during pregnancy. After childbirth, blood remains in the placenta, which can be collected and stored for a fee, for future therapeutic use. The human extra-embryonic tissues (placenta, amniotic membranes, and umbilical cord) as well as human placental fluids (amniotic fluid and umbilical cord blood) were also defined as sources of Mesenchymal stem cells (MSCs), which represents a great interest for biomedical applications. Immunomodulatory properties of human placenta as well as the clinical applicability of such placental parts as amniotic membranes for wound healing, treatment of burns, and reconstruction of the oral cavity are expected to drive its demand.
In terms of application, the global placental stem cell therapy market has been divided into hematologic malignancies and disorders, congenital immunodeficiency disorders, metabolic disorders, neurological disorders, and others. The neurological disorders segment held a significant share of the global placental stem cell therapy market in 2019. Based on end user, the global placental stem cell therapy market has been split into hospitals & specialty clinics, clinical research organizations, and research institutes & academies. The clinical research organizations segment held a significant share of the global placental stem cell therapy market in 2019.
Placental Stem Cell Therapy Market: Prominent Regions
Asia Pacific held a major share of the global placental stem cell therapy market in 2019. Presence of key players and growth strategies adopted by these players are key factors driving the placental stem cell therapy market in the region. North America accounted for the second-largest share of the global placental stem cell therapy market in 2019. The expansion of the market in the region can be attributed to a well-developed healthcare sector. The placental stem cell therapy market in North America is likely to expand at a rapid pace during the forecast period. Technological developments in placental stem cell therapy is another major factor that is likely to propel the placental stem cell therapy market in the region.
Placental Stem Cell Therapy Market: Key Players
Key players are expanding their footprint to consolidate their positions in the global placental stem cell therapy market, due to lucrative opportunities to increase their share. Hence, manufacturers engage in new developments, collaborations, and distribution to gain market share. Leading players operating in the global placental stem cell therapy market include Lifebank Stem Cell Banking, Celularity, Inc., Americord Registry, ReeLabs Pvt. Ltd., Pluristem Therapeutics, Inc., Mesoblast Limited, ReNeuron Group plc, and Athersys, Inc.
Global Placental Stem Cell Therapy Market: Segmentation
Placental Stem Cell Therapy Market, by Application
Placental Stem Cell Therapy Market, by End User
Placental Stem Cell Therapy Market, by Region
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453